Anticoagulants Market By Drug Class (Novel Oral Anticoagulants (NOACs), Vitamin K Antagonists, Heparins & Low Molecular Weight Heparins (LMWH), Antiplatelet Agents, Thrombolytic Agents, Direct Thrombin Inhibitors), By Application (Atrial Fibrillation & Heart Attacks, Strokes, Deep Vein Thrombosis (DVT), Pulmonary Embolism) - Growth, Future Prospects, Competitive Analysis, 2026 - 2034
